Zacks Investment Research on MSN
Here's why you should retain Reliance stock in your portfolio
Reliance, Inc. RS is benefiting from strong end-market demand and strategic acquisitions that are expanding its capabilities ...
Company plans to showcase new volumetric MERFISH datasets in mouse brain and human neurodegenerative brain tissue, generated on the existing MERSCOPE Ultra™ Platform Vizgen, Inc., a leader in spatial ...
Leader in spatial multi-omics technologies launches new generation of MERFISH chemistry and bridges basic and translational research with new pathology-grade, clinically relevant biomarkers CAMBRIDGE, ...
How do bacteria—harmless ones living in our bodies, or those that cause disease—organize their activities? A new study, combining powerful genomic-scale microscopy with a technical innovation, ...
How do bacteria - harmless ones living in our bodies, or those that cause disease - organize their activities? A new study, combining powerful genomic-scale microscopy with a technical innovation, ...
How do bacteria — harmless ones living in our bodies, or those that cause disease — organize their activities? A new study, combining powerful genomic-scale microscopy with a technical innovation, ...
Researchers led by the University of California, Irvine have discovered how the TREM2 R47H genetic mutation causes certain brain areas to develop abnormal protein clumps, called beta-amyloid plaques, ...
A recent Nature study uses a combination of single-cell ribonucleic acid (scRNA)-sequencing and high-resolution multiplexed error-robust fluorescence in situ hybridization (MERFISH) to better ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced that five of the ...
A team of scientists at the Whitehead Institute for Biomedical Research and MIT has spatially mapped the choices stem cells make during tissue regeneration in flatworms, revealing an unexpected ...
In this talk we will explore the application of Multiplexed Error-Robust Fluorescence in situ Hybridization (MERFISH) technology to decode spatially regulated disease drivers in human heart and kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results